Molly Carr

Molly Carr, MD, is the Associate Vice President of Insulins and Glucagon Development at Eli Lilly and Company, where they lead clinical R&D and medical affairs. With extensive experience in business development and clinical trial design, they have worked across various esteemed institutions, including CSL Limited, Wyeth Research, and GSK. Their academic background includes positions as an Assistant Professor at Northwestern University and an Adjunct Assistant Professor of Endocrinology at the University of Pennsylvania. Molly continues to pursue an MD while completing an Internal Medicine residency and an Endocrinology fellowship at the University of Washington.